Group 1 - The core point of the article is that Huajian Medical plans to acquire a 20.31% stake in Guofu Quantum for approximately HKD 3.142 billion, which will be paid through the issuance of 324 million shares at HKD 9.69 per share, making Huajian Medical the controlling shareholder of Guofu Quantum after the acquisition [1] - Guofu Quantum is a comprehensive technology financial platform based in Hong Kong, leveraging the Greater Bay Area and aiming for international reach, with significant resources in quantum computing, artificial intelligence, and blockchain integration [1] - The acquisition is a crucial step for Huajian Medical to advance its RWA exchange strategy and achieve ecological synergy, holding significant industrial and capital value [1] Group 2 - After the acquisition, Huajian Medical will utilize Guofu Quantum's 22.5% stake in Southern Dongying to collaboratively build a blockchain and fintech-centric on-chain financial ecosystem [2] - This platform aims to deeply integrate compliant digital architecture with traditional asset forms, promoting the tokenization, fragmentation, and cross-border flow of assets, thereby creating an efficient, transparent, and interconnected new financial infrastructure [2] - The focus will be on promoting high-quality Chinese assets to go "on-chain" and "overseas" in a compliant and standardized manner, enhancing international recognition and allocation efficiency of Chinese assets through innovative product design and shared international channels [2]
华检医疗(01931.HK)收购国富量子20.31%股权，推进RWA交易所战略持续落地